Atara Biotherapeutics, Inc.·4

Mar 6, 6:18 PM ET

Nguyen AnhCo 4

4 · Atara Biotherapeutics, Inc. · Filed Mar 6, 2024

Insider Transaction Report

Form 4
Period: 2024-03-04
Nguyen AnhCo
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2024-03-04$0.72/sh10,746$7,737941,397 total
Footnotes (2)
  • [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
  • [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

Documents

1 file
  • 4
    form4.xmlPrimary